Poolbeg Pharma PLC (POLBF)
USD 0.15
(27.97%)
USD 0.15
(27.97%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -12.17 Million GBP | 24.84% |
| 2022 | -16.19 Million GBP | 22.7% |
| 2021 | -20.94 Million GBP | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | -14.12 Million GBP | 12.8% |
| 2023 Q2 | -14.12 Million GBP | 0.0% |
| 2023 FY | -12.17 Million GBP | 24.84% |
| 2023 Q3 | -12.17 Million GBP | 13.8% |
| 2023 Q4 | -12.17 Million GBP | 0.0% |
| 2022 Q2 | -18.89 Million GBP | 0.0% |
| 2022 FY | -16.19 Million GBP | 22.7% |
| 2022 Q4 | -16.19 Million GBP | 0.0% |
| 2022 Q3 | -16.19 Million GBP | 14.3% |
| 2022 Q1 | -18.89 Million GBP | 0.0% |
| 2021 Q2 | -23.23 Million GBP | 0.0% |
| 2021 FY | -20.94 Million GBP | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -1708.23% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 1102.646% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 1307.781% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 128.442% |
| GB Sciences, Inc. | 1.74 Million USD | 796.554% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | -37.682% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -131218.014% |
| Skye Bioscience, Inc. | -5.72 Million USD | -112.728% |
| Zenith Capital Corp. | 10.06 Thousand USD | 121036.01% |
| Agentix Corp. | 37.63 Thousand USD | 32443.015% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 315.478% |
| Biomind Labs Inc. | 711.4 Thousand USD | 1810.847% |
| ContraFect Corporation | -6.02 Million USD | -101.975% |
| CSL Limited | 10.52 Billion USD | 100.116% |
| CytoDyn Inc. | 20.26 Million USD | 160.068% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 3483.559% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 2055.608% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 128.022% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -59538.377% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 1412.682% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 2016.189% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | -93.052% |
| SQZ Biotechnologies Company | -36.23 Million USD | 66.414% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 1514.836% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 177.212% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 642.807% |
| Mesoblast Limited | 55.85 Million USD | 121.789% |
| Marizyme, Inc. | 18.56 Million USD | 165.545% |
| Genus plc | 190.6 Million USD | 106.386% |
| Pharming Group N.V. | 109.8 Million USD | 111.084% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 1889.853% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 1153.375% |
| IMV Inc. | 7.67 Million USD | 258.672% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 321.215% |
| MultiCell Technologies, Inc. | 90.04 USD | 13517425.633% |
| ONE Bio Corp. | 9.04 Million USD | 234.634% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 194.014% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 139.834% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 708.735% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 195.037% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 8805.759% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 61362.395% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -6522.304% |
| Enzolytics Inc. | 981.65 Thousand USD | 1339.844% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -2.02 Billion USD | 99.4% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 74.111% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 272.126% |
| Genscript Biotech Corporation | -1.06 Billion USD | 98.853% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 395.554% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 3128.75% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 610.093% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 7498.379% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -66342.843% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 644.361% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 9139.728% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -1558.224% |
| Helix BioMedix, Inc. | -2.57 Million USD | -373.574% |
| EV Biologics, Inc. | 1.36 Million USD | 989.712% |
| Q BioMed Inc. | 4.06 Million USD | 399.778% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 160.027% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 120.102% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | 4.47 Million USD | 372.159% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 652.73% |
| HST Global, Inc. | 96.79 Thousand USD | 12674.256% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -928983.969% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 6002.035% |
| Halberd Corporation | 144.72 Thousand USD | 8509.975% |
| Resverlogix Corp. | 6.45 Million USD | 288.668% |
| Cell Source, Inc. | 9.23 Million USD | 231.835% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 549.344% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | -5.9 Million USD | -106.176% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 6172.384% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | 2.17 Million USD | 658.696% |
| Kadimastem Ltd | -253.1 Thousand USD | -4708.733% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 9049.989% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 6147.582% |
| LadRx Corporation | -2.03 Million USD | -497.652% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 2016.189% |
| Affymax, Inc. | -5.59 Million USD | -117.456% |
| Itoco Inc. | 228.3 Thousand USD | 5431.026% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 345.532% |
| Mobile Lads Corp. | 484.23 Thousand USD | 2613.465% |
| International Stem Cell Corporation | 2.59 Million USD | 569.923% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | 1.89 Million USD | 740.945% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -1881043.74% |
| Qrons Inc. | 351.42 Thousand USD | 3563.308% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 257.942% |
| SYBLEU INC | 473.71 Thousand USD | 2669.272% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -4775.811% |
| Rebus Holdings, Inc. | 305 Thousand USD | 4090.492% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 373.075% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 19600.745% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 658.072% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 454.426% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 242.301% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 1675.316% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -873.68% |
| Neutra Corp. | 52.18 Thousand USD | 23421.9% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | -388.992% |
| PureTech Health plc | -167.19 Million USD | 92.721% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -4869.621% |
| IXICO plc | -4.44 Million USD | -173.839% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 192.072% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 122.189% |
| CSL Limited | 10.52 Billion USD | 100.116% |
| Cellectis S.A. | -43.81 Million USD | 72.224% |